Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Journal of Biopharmaceutical Statistics
|
November 5, 2002
Do you know your total cholesterol (TC) number?
Cong Chen, Zhigang Zhou, Robert W Tipping
The American Journal of Cardiology
|
April 12, 2005
Frequency of myopathy in patients receiving lovastatin
Robert L Wortmann, Robert W Tipping, Jeffrey G Levine, et al.
Journal of Biopharmaceutical Statistics
|
May 6, 2003
Effect of within-household reinfestation on design sensitivity
Cong Chen, A Lawrence Gould, Robert W Tipping, et al.
The Journal of Pediatrics
|
November 1, 2002
An observer-blinded study of 1% permethrin creme rinse with and without adjunctive combing in patients with head lice
Terri L Meinking, Coleen M Clineschmidt, Cong Chen, et al.
Antimicrobial Agents and Chemotherapy
|
February 26, 2020
Comparison of Treatment Outcomes between Analysis Populations in the RESTORE-IMI 1 Phase 3 Trial of Imipenem-Cilastatin-Relebactam versus Colistin plus Imipenem-Cilastatin in Patients with Imipenem-Nonsusceptible Bacterial Infections
Keith S Kaye, Helen W Boucher, Michelle L Brown, et al.
The American Journal of Cardiology
|
November 16, 2004
A Consumer Use Study of Over-The-Counter lovastatin (CUSTOM)
Jeffrey M Melin, William E Struble, Robert W Tipping, et al.
Open Forum Infectious Diseases
|
March 11, 2020
Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study
Michelle L Brown, Johann Motsch, Keith S Kaye, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 11, 2019
RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections
Johann Motsch, Cláudia Murta de Oliveira, Viktor Stus, et al.
American Journal of Epidemiology
|
May 27, 2017
Use of Repeated Blood Pressure and Cholesterol Measurements to Improve Cardiovascular Disease Risk Prediction: An Individual-Participant-Data Meta-Analysis
Ellie Paige, Jessica Barrett, Lisa Pennells, et al.
JAMA
|
July 17, 2012
Lipid-related markers and cardiovascular disease prediction
, Emanuele Di Angelantonio, Pei Gao, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Journal of Biopharmaceutical Statistics
|
November 5, 2002
Do you know your total cholesterol (TC) number?
Cong Chen, Zhigang Zhou, Robert W Tipping
The American Journal of Cardiology
|
April 12, 2005
Frequency of myopathy in patients receiving lovastatin
Robert L Wortmann, Robert W Tipping, Jeffrey G Levine, et al.
Journal of Biopharmaceutical Statistics
|
May 6, 2003
Effect of within-household reinfestation on design sensitivity
Cong Chen, A Lawrence Gould, Robert W Tipping, et al.
The Journal of Pediatrics
|
November 1, 2002
An observer-blinded study of 1% permethrin creme rinse with and without adjunctive combing in patients with head lice
Terri L Meinking, Coleen M Clineschmidt, Cong Chen, et al.
Antimicrobial Agents and Chemotherapy
|
February 26, 2020
Comparison of Treatment Outcomes between Analysis Populations in the RESTORE-IMI 1 Phase 3 Trial of Imipenem-Cilastatin-Relebactam versus Colistin plus Imipenem-Cilastatin in Patients with Imipenem-Nonsusceptible Bacterial Infections
Keith S Kaye, Helen W Boucher, Michelle L Brown, et al.
The American Journal of Cardiology
|
November 16, 2004
A Consumer Use Study of Over-The-Counter lovastatin (CUSTOM)
Jeffrey M Melin, William E Struble, Robert W Tipping, et al.
Open Forum Infectious Diseases
|
March 11, 2020
Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study
Michelle L Brown, Johann Motsch, Keith S Kaye, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 11, 2019
RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections
Johann Motsch, Cláudia Murta de Oliveira, Viktor Stus, et al.
American Journal of Epidemiology
|
May 27, 2017
Use of Repeated Blood Pressure and Cholesterol Measurements to Improve Cardiovascular Disease Risk Prediction: An Individual-Participant-Data Meta-Analysis
Ellie Paige, Jessica Barrett, Lisa Pennells, et al.
JAMA
|
July 17, 2012
Lipid-related markers and cardiovascular disease prediction
, Emanuele Di Angelantonio, Pei Gao, et al.
Page
of 2